Maternal Lifestyle and Neonatal Hypoglycemia
Repercussion of Maternal Lifestyle on Obstetric and Neonatal Outcomes
1 other identifier
interventional
480
1 country
1
Brief Summary
tPA has a pivotal role in placentation, mediationg activation of growth factors, such as vascular endothelial growth factor and brain-derived neurotrophic factor, degradation of extracellular matrix and basement membrane (directly or through activation of matrix metalloproteinases) and formation of hemidesmosomes. A high-carbohydrate intake combined with lack of physical activity provides a strong stimulus for maternal insulin production. In this scenario, either β-cells are dysfunctional and diabetes supervenes, or excessive amounts of insulin are produced, providing pathological stimulation of PAI-1 synthesis. Given that PAI-1 is a major tPA inhibitor, PAI-1 excess may affect placentation, increasing the risk of first trimester losses, preterm deliveries and intrauterine growth restriction. Our hypothesis was that prematurity was not the cause of neonatal hypoglycemia, but a parallel occurrence of a strong stimulus for maternal, fetal and neonatal production of insulin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 27, 2011
CompletedFirst Posted
Study publicly available on registry
August 4, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedResults Posted
Study results publicly available
January 21, 2016
CompletedSeptember 29, 2016
August 1, 2016
2.1 years
May 27, 2011
April 26, 2013
August 19, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neonatal Hypoglycemia
Any glucose level equal or below 40mg/dL at 1, 2 or 4 h after birth, obtained by heelstick.
1, 2 and 4 h after birth.
Secondary Outcomes (1)
Refractory Hypoglycemia
One hour after feeding or after intravenous dextrose
Other Outcomes (1)
Pregnancy and Neonatal Outcomes
Three years
Study Arms (2)
Lifestyle counseling
ACTIVE COMPARATORDaily brisk walking plus a carbohydrate-restricted diet
Standard follow-up
NO INTERVENTIONPrenatal care will proceed according to the routine.
Interventions
Daily brisk walking at moderate speed (4 km/h) for at least 40 minutes per day, 7 days a week. Patients will be recommended to avoid high-glycemic index meals (such as snacks, candies, fiber-free juices and sugar-sweetened beverages), and to eat at least two daily servings of meat, poultry, fish (e.g. 2 g/kg) or other protein-rich food, starting when they decided to get pregnant and continuing until delivery. Recommendations will be emphasised at every appointment. Antidepressants will not be discontinued in both groups, but patients on paroxetine and sertraline, will be switched to fluoxetine.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Federal dos Servidores do Estado
Rio de Janeiro, Rio de Janeiro, 20221-903, Brazil
Related Publications (1)
Hoirisch-Clapauch S, Porto MAS. Early neonatal hypoglycemia prediction according to maternal parameters. Thrombosis Research 131(1): S96, 2013.
RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Silvia Hoirisch-Clapauch
- Organization
- Hospital Federal dos Servidores do Estado
Study Officials
- PRINCIPAL INVESTIGATOR
Maria A Sayeg-Porto, MD, PhD
Hospital dos Servidores do Estado, RJ; Universidade Federal do Rio de Janeiro
- PRINCIPAL INVESTIGATOR
Paulo R Benchimol-Barbosa, MD, DSc
Universidade Gama Filho; COPPE/UFRJ
- PRINCIPAL INVESTIGATOR
Silvia Hoirisch-Clapauch, MD
Hospital dos Servidores do Estado, RJ
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
May 27, 2011
First Posted
August 4, 2011
Study Start
March 1, 2011
Primary Completion
April 1, 2013
Study Completion
October 1, 2015
Last Updated
September 29, 2016
Results First Posted
January 21, 2016
Record last verified: 2016-08
Data Sharing
- IPD Sharing
- Will share